{
  "id": 17095158,
  "title": "Brookline Capital raises Kymera Therapeutics price target on reduced risk",
  "url": "https://urgent.news/2026/10/29/brookline-capital-raises-kymera-therapeutics-price-target-on-reduced",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-29T17:12:54.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/analyst-ratings/brookline-capital-raises-kymera-therapeutics-price-target-on-reduced-risk-93CH-4984815"
  },
  "original_language": "en",
  "account": null,
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}